Haemostasis monitoring during sequential aortic valve replacement and liver transplantation.
Despite advances in anaesthesiological and surgical techniques, cardiac surgery in cirrhotic patients remains hazardous. This report outlines our experience with haemostasis monitoring in two consecutive cases of sequential aortic valve replacement and liver transplantation. Clotting disturbances proved to have fatal consequences since one of these patients died following massive lung embolism. The second patient underwent successfully this combined procedure and is in good clinical state 14 months postoperatively. Evaluation and discussion of the coagulation monitoring by the Sonoclot Analyzer in both patients and related therapeutic suggestions for the prevention of thrombotic events are discussed.
Sieders
E
E
Hepato-Biliary and Liver Transplant Center, Ghent University Hospital Medical School, Ghent, Belgium.
De Somer
F
F
Bouchez
S
S
Szegedi
L
L
Van Belleghem
Y
Y
Colle
I
I
Troisi
R
R
D001024:Aortic Valve Stenosis / Q000097:blood / Q000150:complications / Q000601:surgery*; D019918:Heart Valve Prosthesis Implantation; D006488:Hemostasis, Surgical; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000097:blood / Q000150:complications / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D016343:Monitoring, Intraoperative